Trial · NCT00929344
Results by group27
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 27
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Drinking Quantity and Frequency Using Drinks Per Week at Week 12 | Duloxetine | Drinks/week Baseline | 42.07 | Standard Deviation 17.94 | drinks/week |
| Change From Baseline in Drinking Quantity and Frequency Using Drinks Per Week at Week 12 | Pregabalin | Drinks/week Baseline | 56.67 | Standard Deviation 50.93 | drinks/week |
| Change From Baseline in Drinking Quantity and Frequency Using Drinks Per Week at Week 12 | Placebo | Drinks/week Baseline | 41.20 | Standard Deviation 27.39 | drinks/week |
| Change From Baseline in Drinking Quantity and Frequency Using Drinks Per Week at Week 12 | Duloxetine | Drinks/week Week 12 | 9.16 | Standard Deviation 11.90 | drinks/week |
| Change From Baseline in Drinking Quantity and Frequency Using Drinks Per Week at Week 12 | Pregabalin | Drinks/week Week 12 | 7.59 | Standard Deviation 15.73 | drinks/week |
| Change From Baseline in Drinking Quantity and Frequency Using Drinks Per Week at Week 12 | Placebo | Drinks/week Week 12 | 8.06 | Standard Deviation 11.22 | drinks/week |
| Change From Baseline in Drinking Quantity and Frequency Using Drinks Per Week at Week 12 | Duloxetine | Drinks/week Change | -32.91 | Standard Deviation 20.38 | drinks/week |
| Change From Baseline in Drinking Quantity and Frequency Using Drinks Per Week at Week 12 | Pregabalin | Drinks/week Change | -49.08 | Standard Deviation 44.91 | drinks/week |
| Change From Baseline in Drinking Quantity and Frequency Using Drinks Per Week at Week 12 | Placebo | Drinks/week Change | -33.15 | Standard Deviation 23.32 | drinks/week |
| Change From Baseline in Drinking Quantity and Frequency Using Drinking Days Per Week at Week 12 | Duloxetine | Drinking Days/Week Baseline | 5.11 | Standard Deviation 1.29 | drinking days/week |
| Change From Baseline in Drinking Quantity and Frequency Using Drinking Days Per Week at Week 12 | Pregabalin | Drinking Days/Week Baseline | 4.54 | Standard Deviation 1.64 | drinking days/week |
| Change From Baseline in Drinking Quantity and Frequency Using Drinking Days Per Week at Week 12 | Placebo | Drinking Days/Week Baseline | 4.87 | Standard Deviation 1.60 | drinking days/week |
| Change From Baseline in Drinking Quantity and Frequency Using Drinking Days Per Week at Week 12 | Duloxetine | Drinking Days/Week Week 12 | 2.17 | Standard Deviation 2.59 | drinking days/week |
| Change From Baseline in Drinking Quantity and Frequency Using Drinking Days Per Week at Week 12 | Pregabalin | Drinking Days/Week Week 12 | 1.14 | Standard Deviation 1.90 | drinking days/week |
| Change From Baseline in Drinking Quantity and Frequency Using Drinking Days Per Week at Week 12 | Placebo | Drinking Days/Week Week 12 | 1.85 | Standard Deviation 2.20 | drinking days/week |
| Change From Baseline in Drinking Quantity and Frequency Using Drinking Days Per Week at Week 12 | Duloxetine | Drinking Days/Week Change | -2.94 | Standard Deviation 2.68 | drinking days/week |
| Change From Baseline in Drinking Quantity and Frequency Using Drinking Days Per Week at Week 12 | Pregabalin | Drinking Days/Week Change | -3.40 | Standard Deviation 2.03 | drinking days/week |
| Change From Baseline in Drinking Quantity and Frequency Using Drinking Days Per Week at Week 12 | Placebo | Drinking Days/Week Change | -3.01 | Standard Deviation 2.20 | drinking days/week |
| Change From Baseline in Drinking Quantity and Frequency Using Drinks Per Drinking Day at Week 12 | Duloxetine | Drinks/Drinking Day Baseline | 8.16 | Standard Deviation 2.69 | drinks/drinking day |
| Change From Baseline in Drinking Quantity and Frequency Using Drinks Per Drinking Day at Week 12 | Pregabalin | Drinks/Drinking Day Baseline | 12.98 | Standard Deviation 11.14 | drinks/drinking day |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00929344/results